Avid Bioservices Inc (CDMO)
8.65
+0.51
(+6.27%)
USD |
NASDAQ |
May 10, 16:00
8.65
0.00 (0.00%)
After-Hours: 19:20
Avid Bioservices Enterprise Value: 627.44M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 627.44M |
| May 08, 2024 | 642.67M |
| May 07, 2024 | 666.80M |
| May 06, 2024 | 645.21M |
| May 03, 2024 | 634.42M |
| May 02, 2024 | 631.25M |
| May 01, 2024 | 597.60M |
| April 30, 2024 | 595.06M |
| April 29, 2024 | 590.62M |
| April 26, 2024 | 577.29M |
| April 25, 2024 | 575.39M |
| April 24, 2024 | 544.28M |
| April 23, 2024 | 534.76M |
| April 22, 2024 | 517.62M |
| April 19, 2024 | 516.35M |
| April 18, 2024 | 524.60M |
| April 17, 2024 | 536.66M |
| April 16, 2024 | 570.94M |
| April 15, 2024 | 542.38M |
| April 12, 2024 | 538.57M |
| April 11, 2024 | 548.72M |
| April 10, 2024 | 548.72M |
| April 09, 2024 | 567.13M |
| April 08, 2024 | 532.22M |
| April 05, 2024 | 513.07M |
| Date | Value |
|---|---|
| April 04, 2024 | 513.07M |
| April 03, 2024 | 528.93M |
| April 02, 2024 | 515.61M |
| April 01, 2024 | 518.15M |
| March 28, 2024 | 535.92M |
| March 27, 2024 | 553.68M |
| March 26, 2024 | 541.63M |
| March 25, 2024 | 544.17M |
| March 22, 2024 | 537.82M |
| March 21, 2024 | 546.70M |
| March 20, 2024 | 561.93M |
| March 19, 2024 | 556.22M |
| March 18, 2024 | 529.57M |
| March 15, 2024 | 509.90M |
| March 14, 2024 | 497.20M |
| March 13, 2024 | 507.36M |
| March 12, 2024 | 514.97M |
| March 11, 2024 | 523.22M |
| March 08, 2024 | 536.55M |
| March 07, 2024 | 497.84M |
| March 06, 2024 | 668.55M |
| March 05, 2024 | 637.46M |
| March 04, 2024 | 617.78M |
| March 01, 2024 | 633.65M |
| February 29, 2024 | 598.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
147.23M
Minimum
Mar 20 2020
2.079B
Maximum
Nov 05 2021
817.85M
Average
848.22M
Median
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.056B |
| Creative Medical Technology Holdings Inc | -4.154M |
| Viking Therapeutics Inc | 7.882B |
| Stereotaxis Inc | 165.62M |
| MAIA Biotechnology Inc | 52.33M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.006M |
| Revenue (Quarterly) | 33.82M |
| Total Expenses (Quarterly) | 37.81M |
| EPS Diluted (Quarterly) | -0.09 |
| Gross Profit Margin (Quarterly) | 7.05% |
| Profit Margin (Quarterly) | -17.76% |
| Earnings Yield | -3.18% |
| Normalized Earnings Yield | -3.178 |